Psychedelics Business Transaction Services

Business transactions in the psychedelics sector encompass a wide range of critical activities, including securing financing, ensuring regulatory compliance, protecting intellectual property, and structuring strategic partnerships and agreements. These challenges are similar to those faced by any biotech company, whether their focus is on psychedelic compounds or synthetic small molecules.

At Asebey Life Science Law, we provide comprehensive legal support tailored to the psychedelics industry, ensuring that your ventures are both legally compliant and strategically positioned for success. Our expertise encompasses corporate finance, licensing, mergers and acquisitions, sponsored research agreements, and regulatory adherence. We understand the nuances of this emerging sector and are committed to guiding our clients through the intricacies of these transactions, helping them thrive in a rapidly evolving market.

Our services includes

  • Preparing clients for capital raises
  • Positioning clients for collaborations and / or partnerships with research institutes, other biotech companies, or pharmaceutical companies
  • In- or out-licensing of intellectual property
  • Negotiating sponsored research and material transfer agreements
  • Assisting clients in obtaining Cooperative Research and Development Agreements (CRADAs)
  • Preparing client companies for an exit through an M&A event or licensing of IP portfolios and clinical data to larger biotech or pharmaceutical companies

Tell us more about your regulatory needs so we can help you succeed.

Request a consultation